5'-methylthioadenosine has been researched along with gsk3235025 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aranda, R; Bobinski, TP; Briere, DM; Burns, AC; Christensen, JG; Clarine, J; Engstrom, LD; Gunn, RJ; Ivetac, A; Jean-Baptiste, R; Ketcham, JM; Kobayashi, M; Kuehler, J; Kulyk, S; Lawson, JD; Marx, MA; Moya, K; Olson, P; Rahbaek, L; Smith, CR; Thomas, NC; Wang, X; Waters, LM | 1 |
| Bielski, CM; Boehm, JS; Bradner, JE; Clish, CB; Cowley, GS; Dennis, C; Fitzgerald, ME; Garraway, LA; Golub, TR; Hahn, WC; Kryukov, GV; Marlow, SE; Paulk, J; Root, DE; Ruth, JR; Scott, JM; Tanaka, M; Tsherniak, A; Vazquez, F; Weir, BA; Wilson, FH | 1 |
2 other study(ies) available for 5'-methylthioadenosine and gsk3235025
| Article | Year |
|---|---|
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxyadenosines; Female; Gene Deletion; Humans; Mice, Nude; Neoplasms; Phthalazines; Protein Binding; Protein-Arginine N-Methyltransferases; Purine-Nucleoside Phosphorylase; Thionucleosides; Xenograft Model Antitumor Assays | 2022 |
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
Topics: Cell Line, Tumor; Deoxyadenosines; Enzyme Inhibitors; Gene Deletion; Humans; Isoquinolines; Neoplasms; Protein-Arginine N-Methyltransferases; Purine-Nucleoside Phosphorylase; Pyrimidines; Thionucleosides; Transcription Factors | 2016 |